Business Daily from THE HINDU group of publications
Tuesday, Oct 31, 2006
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate Results - Pharmaceuticals
Get Latest BSE Quote
GSK Pharma net falls 7%

Our Bureau

Sale of animal health business, vaccines shortage behind dip

Mumbai , Oct. 30

The sale of its animal health business, a post-festival backlog and a shortage of vaccines have contributed to the fall in GlaxoSmithKline Pharmaceuticals Ltd's (GSKPL) net profit by 7 per cent, for the quarter ended September 30.

GSKPL clocked a net profit of Rs 285.43 crore for the quarter ended September 30, as compared to Rs 309.33 crore for the same quarter in the previous year. Total income was also marginally down at Rs 424.51 crore (Rs 438.41 crore).

Sale approved

The company's board of directors also approved the sale of its animal health business as a going concern to Virbac Animal Health India Pvt Ltd for a total consideration of Rs 207 crore, GSK Pharma told the Bombay Stock Exchange on Monday. The sale is effective from July 31, 2006.

The sale of GSK's animal health business became effective from August 1, so its performance is reflected only in the first seven months of total sales. But for the quarter under review, sales from the animal health business is reflected only in the first month (July), a GSK Pharma spokesperson told Business Line.

Other reasons

The other reason for a decline in profit and dip in sales is that orders worth Rs 20 crore from the eastern region could not be executed due to the festival season. Also, there were shortages in the availability of biological products, such as vaccines, imported into the country.

These product shortages have been addressed, but they impacted the company's performance, the official said.

GSK Pharma closed 2.14 per cent down on the BSE at Rs 1,133.10.

More Stories on : Pharmaceuticals | Glaxosmithkline Pharmaceuticals Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Godrej Ind clocks Rs 12.64-cr net


Tata Chem net up 25%
ITC net profit grows 18.7%
Reliance Comm posts Rs 702-cr net in Q2
Deccan Aviation Q1 net loss at Rs 42 cr
Birla Corp net up at Rs 67.54 cr
Madras Cements Q2 net quadruples
GHCL Q3 net sales up 17 pc
MRPL net profit drops to Rs 9 cr
GAIL Q2 net down 42 pc, turnover rises marginally
GSK Pharma net falls 7%
Aurobindo Pharma posts higher net
NTPC profit up 26.6%
Varun Shipping Q2 net up at Rs 45 cr
SAIL net up 28% in Q2
Monnet Ispat plans special purpose vehicle
Tata Steel Q2 net rises to Rs 1,101 cr
Jindal Steel net up 8 pc in Q2
Parry Agro net up at Rs 31.9 cr
Tata Motors Q2 net up 31%
Amara Raja PAT up at Rs 12.7 cr
Blue Star Q2 net rises 58.75 pc
ABB net rises 55%; order book rise 48%
Heritage Foods to launch pilot stores in November
IVRCL net up 39%
Sasken Tech net at over Rs 11 cr
Forex loss, tax charge dent MphasiS BFL net
Asian Paints Q2 net rises 27 pc; to pay Rs 5.50 interim
YES Bank Q2 net up 50 pc
Oriental Bank's Q2 net up 51 pc after GTB write-offs
Robust interest income lifts IOB net 25 pc
Indian Bank net grows 60 pc
UCO keen to rejig capital
PNB posts 20-pc rise in PAT; deposit costs down
Syndicate Bank Q2 net rises 17%
Simone Tata steps down


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line